Rituximab in lymphocyte-predominant Hodgkin disease: Results of a phase 2 trial
Bradley C. Ekstrand, Jennifer B. Lucas, Steven M. Horwitz, Zhen Fan, Sheila Breslin, Richard T. Hoppe, Yasodha Natkunam, Nancy L. Bartlett, Sandra J. Horning
Dive into the research topics of 'Rituximab in lymphocyte-predominant Hodgkin disease: Results of a phase 2 trial'. Together they form a unique fingerprint.